
Keros Therapeutics Inc (KROS) receives a Neutral rating from BofA Securities
Keros Therapeutics Inc’s recent filing unveils that its 10% Owner ADAR1 Capital Management, LLC acquired Company’s shares for reported $9.46
Keros Therapeutics Inc’s recent filing unveils that its 10% Owner ADAR1 Capital Management, LLC acquired Company’s shares for reported $9.46
In a filing, Loar Holdings Inc revealed its 10% Owner Blackstone Holdings IV L.P. unloaded Company’s shares for reported $247.83
Century Communities Inc’s filing revealed that its Director Ramirez Elisa Z acquired Company’s shares for reported $80790.0 on Apr 28
Vimeo Inc’s recently made public that its Director Schiffman Glenn acquired Company’s shares for reported $0.11 million on Feb 24
Ares Capital Corp’s recent filing unveils that its Co-President Miller James Robert acquired Company’s shares for reported $0.93 million on
In a filing, Prelude Therapeutics Inc revealed its Chief Chemistry Officer Combs Andrew acquired Company’s shares for reported $69250.0 on
Magnera Corp’s filing revealed that its Director Curless Michael S acquired Company’s shares for reported $0.12 million on Jun 04
Urban Edge Properties’s recently made public that its General Counsel and Secretary Milton Robert C unloaded Company’s shares for reported
Choiceone Financial Services, Inc’s recent filing unveils that its Director Coulter Curt E acquired Company’s shares for reported $298.0 on
In a filing, GrafTech International Ltd revealed its Director Shivaram Sachin M acquired Company’s shares for reported $25500.0 on May